Tigermed
Integrated CRO platform enabling life-changing therapies with end-to-end clinical and preclinical services globally.
Leading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers. Headquartered in Hangzhou, China.
Phases
Indications / Therapeutic Areas
Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Clinical Trial Services
- Clinical Imaging Core Lab
- Central Laboratory Services
- Medical Writing
- Pharmacovigilance & Drug Safety
- Biostatistics & Statistical Programming
- Data Management & eClinical
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- China NMPA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- Device & Combination Product Services
- Translational Research
- GLP Toxicology
- In Vitro ADME / DMPK
- In Vitro Pharmacology
- Preclinical In Vitro Studies
- In Vivo PK / PD Studies
- In Vivo Efficacy Models
- Preclinical In Vivo Studies
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Medicinal Chemistry
- High-Throughput Screening
- Oncology Specialty Services
- Cardiovascular & Metabolic Specialty Services
- CNS Specialty Services
- Immunology & Inflammation Services
- Virology Services
- Microbiology Services
Modalities
Technical specifications & accreditations
Accreditations
About this organization
Tigermed is an integrated biopharmaceutical research and development services platform offering comprehensive CRO capabilities across the full drug development lifecycle.
Service Areas:
- Preclinical Development: Medicinal chemistry, compound screening, DMPK, safety & toxicology, bioanalytical services
- Clinical Development: Medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, clinical development strategy, decentralized clinical trials (DCTs), site management (SMO)
- Medical Device & IVD: Dedicated medical device and in vitro diagnostic CRO services
- Integrated Capabilities: Medical imaging, pharmacovigilance, medical translation, quality assurance, GMP consulting, central laboratories, EDC systems, remote follow-up centers
- Real World Study: Real-world data and evidence generation for post-marketing studies
- Therapeutic Expertise: Cell and gene therapy, GLP-1 RA, radiopharmaceutical, infectious diseases, oncology, hematology, cardiovascular, endocrinology, rheumatology, CNS, gastroenterology, ophthalmology
Global Reach: 11,000+ employees across 180+ offices and locations spanning five continents, supporting 4,000+ global customers and 170+ innovative drugs.
Locations
Headquarters
Hangzhou · Zhejiang · China
Global Offices
Multiple · Global · Multiple (180+ locations across 5 continents)
Related companies
Similar profiles by shared services, phases, and indications.
Medpace- Phase I Clinical Trials
- Phase II Clinical Trials
Premier Research- Phase I Clinical Trials
- Phase II Clinical Trials
Labcorp- Phase I Clinical Trials
- Phase II Clinical Trials
Certara- Phase I Clinical Trials
- Phase II Clinical Trials
ICON plc- Phase I Clinical Trials
- Phase II Clinical Trials
ICON- Phase I Clinical Trials
- Phase II Clinical Trials
IQVIA- Phase I Clinical Trials
- Phase II Clinical Trials
Syneos Health- Phase I Clinical Trials
- Phase II Clinical Trials
Submit a verified review for this organization.
Markdown mirror: /companies/tigermedgrp.md